Price T Rowe Associates Inc Ars Pharmaceuticals, Inc. Comm Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Price T Rowe Associates Inc holds 462,519 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
462,519
Previous 15,720 2842.23%
Holding current value
$0
Previous $134,000 4905.22%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
N/A
446,799 Added 2842.23%
462,519 $6.71 Million
Q2 2024

Aug 14, 2024
BUY
N/A
15,720 New
15,720 $134,000
Q2 2023

Aug 14, 2023
BUY
N/A
4,936 Added 42.55%
16,537 $111,000
Q1 2023

May 15, 2023
BUY
N/A
11,601 New
11,601 $76,000
Q3 2022

Nov 14, 2022
SELL
N/A
-139,700 Reduced 84.06%
26,500 $140,000
Q2 2022

Aug 15, 2022
SELL
N/A
-134,374 Reduced 44.71%
166,200 $705,000
Q1 2022

May 16, 2022
BUY
N/A
900 Added 0.3%
300,574 $1.06 Million
Q4 2021

Feb 14, 2022
BUY
N/A
299,674 New
299,674 $2 Million

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email